Hansmann, Sandra
Lainka, Elke
Horneff, Gerd
Holzinger, Dirk
Rieber, Nikolaus
Jansson, Annette F.
Rösen-Wolff, Angela
Erbis, Gabi
Prelog, Martina
Brunner, Juergen
Benseler, Susanne M.
Kuemmerle-Deschner, Jasmin B. http://orcid.org/0000-0002-6365-6598
Article History
Received: 28 October 2019
Accepted: 3 February 2020
First Online: 17 February 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: S.H. received honoraria from Novartis Pharma for Advisory Board attendance.E.L. received speaker honoraria from Novartis and SOBI and funding for the AID-registry by the Federal Ministry of Education and Research (BMBF: 01GM08104, 01GM1112D, 01GM1512D).G.H. received speaker honoraria from Novartis, MSD, Bayer, Bristol-Myers, Sobi, Boehringer and Chugai and received research grants from AbbVie, Chugai, Novartis, Pfizer, Roche and MSD.D.H. received speaker honoraria from Novartis Pharma.N.R. received research grants, travel grants for Advisory Board attendance and speaker honoraria from Novartis.A.J. has no financial disclosures.A.R.-W. received research grants, travel grants for Advisory Board attendance and speaker honoraria from Novartis.G.E. was partially funded through the Margarete Mueller-Bull Stiftung and a research grant of Novartis Pharma. G.E. also received speaker honoraria from Novartis Pharma.M.P. received speaking honoraria from Novartis, MSD, Pfizer, SOBI and Chugai and received research grants from Novartis, SOBI, Pfizer and Chugai.J.B. received speaker’s bureaus or consulting fees from AbbVie, Novartis, and Pfizer.S.B. received speaker honoraria from Novartis and SOBI.J.B.K.-D. performed clinical studies with and received educational, research and centre grants and honoraria from Novartis, AbbVie and SOBI.